E
EUROFARMA LABORAT?RIOS S/A
Eurofarma Laboratórios S.A. is a Brazilian multinational corporation engaged in biopharmaceuticals and is one of the largest medicaments producer in Brazil and Latin America. Eurofarma has active operations in 20 countries,
Country/Area ：Brazil
Company Email ：john@eurofarma.com.br
Industry ：RetailDrug Stores & Pharmacies
Company address ：3465 Avenida Vereador Jose Diniz Campo Belo, Sao Paulo, Sao Paulo, 04603-000, Brazil
Company website ：*****
Company phone ：+55 1150908600
Established ：1972
Company Revenue ：$451,114,000
Number of employees ：3119
SIC Code ：87873
NAICS Code ：54541
Company News
Eurofarma Ventures to invest up to USD$100 million in biotechs - Contxto
Nov 16, 2023
Eurofarma, a Brazilian pharmaceutical company, created a corporate venture capital fund to invest in biotechnology startups.
Nov 16, 2023
Pfizer and BioNTech Announce Collaboration With Brazil’s Eurofarma to Manufacture COVID-19 Vaccine Doses for Latin AmericaAug 26, 2021
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the signing of a letter of intent with Eurofarma Laboratórios SA, a Brazilian biopharmaceutical company, to manufacture COMIRNATY® (COVID-19 Vaccine, mRNA) for distribution within Latin America. Eurofarma will perform manufacturing activities within Pfizer’s and BioNTech’s global COVID-19 vaccine supply chain and manufacturing network, which will now span four continents and includ
Aug 26, 2021Pacira Announces EXPAREL Distribution Agreement with Eurofarma in Latin AmericaJun 22, 2021
PARSIPPANY, N.J., June 22, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today announced that it has entered into a distribution agreement with Eurofarma Laboratories S.A. (Eurofarma) for the development and commercialization of EXPAREL® (bupivacaine liposome injectable suspension) in Latin America.
Jun 22, 2021Eurofarma Synapsis Receives Registrations Until June 21May 9, 2019
Sustainable entrepreneurship platform in Latin America in partnership with Endeavor, encourages innovation in health area. [PR.com]
May 9, 2019NLS-1 Pharma and Eurofarma Enter to an Exclusive Licensing Agreement to Develop and Commercialize Nolazol® for the Treatment of ADHD in Latin AmericaFeb 21, 2019
STANS, Switzerland, Feb. 21, 2019 (GLOBE NEWSWIRE) -- NLS-1 Pharma (NLS), a Swiss biotech firm focusing on the development of novel treatments for Attention-Deficit/Hyperactivity Disorder (ADHD) and other cognitive disorders and impairments, today announced an exclusive license agreement to develop and commercialize its clinical-stage ADHD therapy, Nolazol® (Mazindol CR), in Central & South America (Latin America) with Eurofarma, a Brazilian pharmaceutical company with a presence in 20 Latin
Feb 21, 2019Web Summary
Q1: Where is the company Eurofarma Laboratórios S/A located?
A1: The company Eurofarma Laboratórios S/A is based in Brazil, but its exact address is not specified in the provided text.
Q2: What type of products does Eurofarma offer?
A2: Eurofarma offers a wide range of pharmaceutical products, including genéricos (generic), hospitalar (hospital), oncologia (oncology), prescrição médica (prescription medicine), and alimentos/suplementos alimentares (food/supplements).
Q3: What is the area of atuação (operation) of Eurofarma?
A3: The area of atuação of Eurofarma is not explicitly stated in the provided text, but based on the information available, it appears to be focused on pharmaceuticals and healthcare.
Q4: What services does Eurofarma offer?
A4: Eurofarma offers various services, including farmacovigilância (pharmacovigilance), pesquisa clínica (clinical research), pesquisa e desenvolvimento (research and development), EurON (a sustainable development program), and others.
Q5: What is the purpose of the Cartilha de Sustentabilidade (Sustainability Chart) published by Eurofarma?
A5: The Cartilha de Sustentabilidade is a document that summarizes the company's actions in social, environmental, and cultural areas. It appears to be an effort to promote sustainability and transparency.
Q6: What is the Eurolab program offered by Eurofarma?
A6: Eurolab is a biotechnology innovation program offered by Eurofarma, which aims to develop new products and technologies for the pharmaceutical industry.
Q7: How many atendimentos diretos (direct services) has the Instituto Eurofarma performed since its founding in 2006?
A7: The Instituto Eurofarma has performed over 100,000 direct services since its founding in 2006, primarily focusing on education, environmental issues, and youth development.
Q8: What is the vision of Eurofarma regarding sustainability?
A8: Eurofarma's vision is to be a sustainable company that prioritizes the well-being of people and the environment. The company aims to reduce its impact on the environment and promote responsible practices throughout its operations.
A1: The company Eurofarma Laboratórios S/A is based in Brazil, but its exact address is not specified in the provided text.
Q2: What type of products does Eurofarma offer?
A2: Eurofarma offers a wide range of pharmaceutical products, including genéricos (generic), hospitalar (hospital), oncologia (oncology), prescrição médica (prescription medicine), and alimentos/suplementos alimentares (food/supplements).
Q3: What is the area of atuação (operation) of Eurofarma?
A3: The area of atuação of Eurofarma is not explicitly stated in the provided text, but based on the information available, it appears to be focused on pharmaceuticals and healthcare.
Q4: What services does Eurofarma offer?
A4: Eurofarma offers various services, including farmacovigilância (pharmacovigilance), pesquisa clínica (clinical research), pesquisa e desenvolvimento (research and development), EurON (a sustainable development program), and others.
Q5: What is the purpose of the Cartilha de Sustentabilidade (Sustainability Chart) published by Eurofarma?
A5: The Cartilha de Sustentabilidade is a document that summarizes the company's actions in social, environmental, and cultural areas. It appears to be an effort to promote sustainability and transparency.
Q6: What is the Eurolab program offered by Eurofarma?
A6: Eurolab is a biotechnology innovation program offered by Eurofarma, which aims to develop new products and technologies for the pharmaceutical industry.
Q7: How many atendimentos diretos (direct services) has the Instituto Eurofarma performed since its founding in 2006?
A7: The Instituto Eurofarma has performed over 100,000 direct services since its founding in 2006, primarily focusing on education, environmental issues, and youth development.
Q8: What is the vision of Eurofarma regarding sustainability?
A8: Eurofarma's vision is to be a sustainable company that prioritizes the well-being of people and the environment. The company aims to reduce its impact on the environment and promote responsible practices throughout its operations.
Customs Data
As a purchaser
As a Supplier
Get the Whole details
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Get the Whole details
